VUMC Part of New Study Validating Curative Therapy for Sickle Cell Disease
March 01, 2025
March 01, 2025
NASHVILLE, Tennessee, March 1 -- Vanderbilt University Medical Center issued the following news release:
* * *
VUMC part of new study validating curative therapy for sickle cell disease
Of 38 adults with severe SCD who participated in the study, more than 97% no longer required immunosuppressive therapy one year after the transplant.
A modified bone marrow transplant procedure for sickle cell disease (SCD) co-developed at Vanderbilt University . . .
* * *
VUMC part of new study validating curative therapy for sickle cell disease
Of 38 adults with severe SCD who participated in the study, more than 97% no longer required immunosuppressive therapy one year after the transplant.
A modified bone marrow transplant procedure for sickle cell disease (SCD) co-developed at Vanderbilt University . . .